What is the role of ganciclovir and foscarnet in the treatment of cytomegalovirus (CMV) encephalitis in HIV?

Updated: Jan 08, 2020
  • Author: Regina Krel, MD; Chief Editor: Niranjan N Singh, MBBS, MD, DM, FAHS, FAANEM  more...
  • Print


Ganciclovir and foscarnet are indicated for CMV infections in the induction phase. The 2 agents may be used in combination, although this combination results in substantial rates of adverse effects. [7, 6] Long-term intravenous (IV) maintenance therapy may be indicated for patients who have a clinical response.

Suggested dosing: IV gancyclovir (5 mg/kg every 12 hours) plus foscarnet (90 mg/kg every 12 hours). [8]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!